Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test if delaying the start of the olaparib until there is a
rise in a tumor marker called CA-125 will result in a longer time until the next or different
treatment for the patient's cancer. The study will also evaluate how delaying the start of
maintenance therapy will affect symptoms; physical functioning; quality of life; and impact
on finances.